BioXcel’s agitation drug gets FDA Fast TrackThe FDA has granted Fast Track Designation to BioXcel Therapeutics’ BXCL501 for the treatment of acute agitation resulting Share XBioXcel’s agitation drug gets FDA Fast Trackhttps://pharmaphorum.com/news/bioxcels-agitation-drug-gets-fda-fast-track/